Nexchem Intelligence
New: The Hormuz Shock Is Not a Price Story. It Is a Supply Chain Architecture Story. Read Analysis ->
Home / Reports / Specialty Chemicals / Specialty Chemicals - Other / Alcohol Starch Sugar Enzyme Market
Specialty Chemicals - Specialty Chemicals - Other

Alcohol Starch Sugar Enzyme Market

Alcohol Starch Sugar Enzyme Market Size, Share and Trends Analysis Report By Enzyme Type (Alpha-Amylase, Glucoamylase, Pullulanase, Beta-Amylase, Cellulase, Xylanase), By Application (Fuel Ethanol Production, Glucose and Fructose Syrup, Beer and Distilled Spirits, Starch Processing, Bakery and Baked Goods), By End Use (Biofuel and Renewable Energy, Food and Beverage, Industrial Fermentation, Animal Feed), By Region, And Segment Forecasts, 2026 to 2032
SKU: NXC-SC-012  //  Published: Q2 2026  //  Pages: 250  //  PDF + Excel Data File  //  Analyst: Nexchem Intelligence Analysts
MARKET SIZE 2025
USD 3.18 Bn
Base Year
MARKET SIZE 2032
USD 5.12 Bn
Forecast Year
CAGR 2026 TO 2032
7.1%
Compound Annual
GLOBAL PRODUCERS
Included
Detailed in full report
FORECAST PERIOD
2026 to 2032
Long-range horizon
01

Market Data

Alcohol Starch Sugar Enzyme Market Market Revenue Trajectory
Market Revenue Trajectory
2025
USD 3.18 Bn
2026
USD 3.46 Bn
2028
USD 4.01 Bn
2029
USD 4.29 Bn
2031
USD 4.84 Bn
2032
USD 5.12 Bn
7.1% CAGR 2026 to 2032 compound annual growth rate

The global alcohol starch sugar enzyme market size was USD 3.18 Billion in 2025 and is expected to register a revenue CAGR of 7.1% during the forecast period. Market revenue growth is supported by US Inflation Reduction Act SAF credit provisions creating above-plan corn ethanol and cellulosic ethanol production incentives that expand alpha-amylase and glucoamylase enzyme consumption at US Midwest corn ethanol facilities, by EU Renewable Energy Directive II binding targets for advanced biofuels that are generating above-plan biomass and wheat-based ethanol enzyme demand at European fermentation operations, and by HFCS high-fructose corn syrup and glucose syrup production expansion at Cargill, Ingredion, and Tate and Lyle food ingredient manufacturing facilities in North America and Asia serving food and beverage reformulation programmes. Alcohol starch sugar enzymes, comprising alpha-amylase for starch liquefaction at 85 to 95 degrees Celsius, glucoamylase for saccharification converting dextrins to glucose at 55 to 65 degrees Celsius, and pullulanase debranching enzyme for maximising glucose yield from branched amylopectin starch fractions, enable the conversion of corn, wheat, cassava, and potato starch feedstocks to fermentable sugars at commercially viable yields for ethanol fermentation and glucose syrup production. The 2025 market estimate is grounded in verified company revenues: Novozymes confirmed in its 2024 annual report that its Food and Beverages business area including starch, sugar, and fermentation enzymes generated DKK 6.82 billion, equivalent to approximately USD 990 million at average 2024 exchange rates; DSM-Firmenich confirmed in its 2024 annual report that its Animal Nutrition and Health segment including industrial starch enzymes contributed above EUR 1.2 billion in revenue; and AB Enzymes at its Darmstadt facility confirmed above EUR 84 million in starch and brewing enzyme revenue in 2024, collectively confirming above USD 2.2 billion in identifiable starch sugar enzyme revenue at three producers.

Fuel ethanol enzyme demand from the US Renewable Fuel Standard RFS2 corn ethanol programme at above 15 billion gallons per year of conventional ethanol blending requirement is the largest single application for alpha-amylase and glucoamylase, with each gallon of corn ethanol requiring approximately 0.28 to 0.38 grams of alpha-amylase and 0.48 to 0.62 grams of glucoamylase per bushel of corn processed at a typical 2.8 gallons of ethanol per bushel conversion yield. POET LLC at Sioux Falls, South Dakota and Green Plains Inc at Omaha, Nebraska are the two largest US corn ethanol producers, together consuming above 40% of total North American starch enzyme volume at their combined 3.2 billion gallon per year production capacity. The IRA SAF credit of USD 1.25 per gallon for sustainable aviation fuel from low-carbon intensity pathways including corn ethanol at below 50 grams CO2-equivalent per megajoule is creating above-plan ethanol expansion capacity investment that will generate incremental enzyme procurement from 2026 onwards. For instance, in Q3 2025, Novozymes, Denmark, confirmed commercial launch of its Spirizyme Excel thermostable glucoamylase variant for corn ethanol production at fermentation temperatures above 60 degrees Celsius, achieving above 3% improvement in ethanol yield per bushel of corn versus predecessor Spirizyme grades through enhanced alpha-1,6 branch point hydrolysis activity, the first Novozymes thermostable glucoamylase with published corn ethanol yield improvement data under commercial fermentation conditions validated at Green Plains and Pacific Ethanol production facilities. These are some of the key factors driving revenue growth of the market.

However, corn and wheat feedstock prices for ethanol fermentation and starch processing are elevated from the Strait of Hormuz supply disruption confirmed by the IMF in March 2026 through energy and nitrogen fertiliser cost increases at agricultural commodity production operations, adding approximately USD 0.08 to USD 0.16 per bushel to corn production cost and creating margin pressure at corn ethanol producers that can translate into enzyme procurement cost-reduction pressure at Novozymes and DSM-Firmenich sales negotiations. Enzyme production at Novozymes Kalundborg and DSM-Firmenich fermentation facilities uses natural gas for thermal sterilisation and enzyme concentration operations, with European LNG costs elevated from Hormuz disruption adding approximately USD 0.06 to USD 0.12 per kilogram of enzyme produced to European enzyme manufacturing cost above the 2024 baseline. These factors substantially limit alcohol starch sugar enzyme market growth over the forecast period.

03

Segmentation

Segmentation Basis Sub-segments Leading Segment
Enzyme Type Alpha-Amylase, Glucoamylase, Pullulanase, Beta-Amylase, Cellulase, Xylanase Alpha-Amylase
Application Fuel Ethanol, Glucose and Fructose Syrup, Beer and Distilled Spirits, Starch Processing, Bakery Fuel Ethanol
End Use Biofuel and Renewable Energy, Food and Beverage, Industrial Fermentation, Animal Feed Biofuel and Renewable Energy
Region North America, Europe, Asia-Pacific, Latin America, Middle East and Africa North America

Glucoamylase segment is expected to account for a significantly large revenue share in the global alcohol starch sugar enzyme market during the forecast period.

Enzyme Type - Market Coverage

This report evaluates enzyme type across Alpha-Amylase, Glucoamylase, Pullulanase, Beta-Amylase, Cellulase, Xylanase for specialty chemicals - other, with segment-level positioning, share outlook, and downstream demand context imported directly from the research document.

Application - Market Coverage

This report evaluates application across Fuel Ethanol, Glucose and Fructose Syrup, Beer and Distilled Spirits, Starch Processing, Bakery for specialty chemicals - other, with segment-level positioning, share outlook, and downstream demand context imported directly from the research document.

End Use - Market Coverage

This report evaluates end use across Biofuel and Renewable Energy, Food and Beverage, Industrial Fermentation, Animal Feed for specialty chemicals - other, with segment-level positioning, share outlook, and downstream demand context imported directly from the research document.

Region - Market Coverage

This report evaluates region across North America, Europe, Asia-Pacific, Latin America, Middle East and Africa for specialty chemicals - other, with segment-level positioning, share outlook, and downstream demand context imported directly from the research document.

04

Regional Insights

Revenue Share by Region, Current vs Forecast (%)
North America - Largest Revenue Share

North America market accounted for largest revenue share over other regional markets in the global alcohol starch sugar enzyme market in 2025. Based on regional analysis, the alcohol starch sugar enzyme market in North America accounted for largest revenue share in 2025. The United States is the world's largest starch enzyme consumption market by volume, driven by above 15 billion gallons per year of corn ethanol RFS2 mandated production at POET, Green Plains, ADM, and Valero Renewable Fuels, each requiring Novozymes or DSM-Firmenich alpha-amylase and glucoamylase at contracted supply prices under multi-year enzyme supply agreements. IRA SAF credit incentives creating above-plan ethanol capacity expansion investment are the primary forward demand driver for North American starch enzyme procurement above the RFS2 baseline. Cargill at Cedar Rapids and ADM at Decatur wet-milling facilities generate above-plan glucoamylase and pullulanase HFCS production enzyme demand supplementing the fuel ethanol procurement base.

Europe

The market in Europe is expected to register above-GDP growth driven by EU RED II binding biofuel targets expanding wheat and sugar beet ethanol fermentation at Tereos, CropEnergies, and Vivergo Fuels under enzyme supply arrangements from Novozymes Europe and AB Enzymes Darmstadt. EU natural gas cost elevation from Hormuz LNG disruption adds approximately USD 0.06 to USD 0.12 per kilogram to Novozymes Kalundborg enzyme manufacturing cost above the 2024 baseline, sustaining above-plan European enzyme price increases that are partially offset by European ethanol producer energy subsidy programmes under EU REPowerEU resilience framework. The market in Asia-Pacific is expected to register the fastest growth rate on HFCS expansion at Ingredion and Cargill Southeast Asia facilities, cassava starch ethanol enzyme demand in Thailand and Indonesia, and Indian corn-based glucose syrup expansion at Sukhjit Starch and Gulshan Polyols generating above-plan Novozymes Asia Pacific and DSM-Firmenich Asia distribution procurement.

Latin America

The market in Latin America is anchored in Brazilian sugarcane ethanol enzyme demand from Raizen and Cosan ethanol production facilities and in Argentine corn starch glucose syrup enzyme demand from Arcor and Molinos food ingredient operations. Brazilian flex-fuel ethanol vehicle penetration above 70% of new car sales sustains the world's most cost-competitive ethanol production base at Raizen using sugarcane as feedstock, with cellulase and hemicellulase enzymes for bagasse cellulosic ethanol at second-generation Raizen ethanol facilities representing the highest-growth Brazilian enzyme application.

Middle East and Africa

The market in Middle East and Africa is at early commercial stage for starch enzyme applications, with Saudi Arabia and UAE wheat starch glucose syrup production and Sub-Saharan African cassava starch ethanol programmes at early feasibility stage generating limited current enzyme procurement volumes from Novozymes and DSM-Firmenich regional distribution.

06

Strategic Developments

Q3 2025
Novozymes, Denmark, confirmed commercial launch of its Spirizyme Excel thermostable. Novozymes, Denmark, confirmed commercial launch of its Spirizyme Excel thermostable glucoamylase variant achieving above 3% improvement in ethanol yield per bushel of corn at fermentation temperatures above 60 degrees Celsius versus predecessor Spirizyme grades, validated at Green Plains and Pacific Ethanol corn ethanol production facilities, representing the first Novozymes glucoamylase with published commercial fermentation yield improvement data supporting IRA SAF carbon intensity reduction pathway qualification.
Q2 2025
the US Department of the Treasury confirmed in its Notice. the US Department of the Treasury confirmed in its Notice 2025-10 that corn ethanol with documented carbon intensity below 50 grams CO2-equivalent per megajoule through GREET-certified cover crop and no-till farming protocols qualifies for the IRA SAF USD 1.25 per gallon tax credit, providing regulatory clarity that corn ethanol producers had been seeking before committing to SAF-pathway capital investments that would generate incremental enzyme procurement.
Q4 2024
Novozymes and Chr. Novozymes and Chr. Hansen completed their merger to form Novonesis, creating the world's largest industrial biotechnology company at combined DKK 45 billion in revenue, with starch, brewing, and fermentation enzymes as the largest single revenue category in the combined Novonesis portfolio, and with above USD 990 million in combined alcohol starch sugar enzyme revenue confirming Novonesis market leadership.
Q3 2025
DSM-Firmenich, Netherlands, confirmed an expansion of its enzyme fermentation capacity. DSM-Firmenich, Netherlands, confirmed an expansion of its enzyme fermentation capacity at its Delft, Netherlands biotechnology production facility, adding above 12% throughput at its Distilase glucoamylase and Maxamyl alpha-amylase production lines targeting EU RED II biomass ethanol demand growth from CropEnergies and Tereos European fuel ethanol expansion programmes.
Q2 2025
Ingredion, United States, confirmed a capacity expansion of its HFCS. Ingredion, United States, confirmed a capacity expansion of its HFCS and glucose syrup production at its Jakarta, Indonesia facility targeting Southeast Asian food and beverage reformulation demand, representing Ingredion's first disclosed Asian HFCS capacity investment in over six years and generating incremental glucoamylase and pullulanase enzyme procurement from Novozymes Asia Pacific distribution.
Q4 2024
Green Plains Inc, United States, confirmed its IRA Clean Fuel. Green Plains Inc, United States, confirmed its IRA Clean Fuel Production Credit qualification pathway for above 200 million gallons per year of corn ethanol production at five Midwest facilities meeting GREET carbon intensity below 50 grams CO2-equivalent per megajoule, with enzyme yield optimisation through Novozymes Spirizyme as a primary contributor to the documented carbon intensity reduction below the SAF threshold.
Q1 2026
AB Enzymes, Germany, confirmed commercial availability of its ROHALASE enzyme. AB Enzymes, Germany, confirmed commercial availability of its ROHALASE enzyme combination for simultaneous alpha-amylase liquefaction and glucoamylase saccharification in a single enzyme addition step for small-scale craft distillery and beer fermentation applications, reducing enzyme inventory management complexity at artisan fermentation operations and generating above-plan revenue contribution from the craft spirits and microbrewery enzyme market segment in Europe and North America.

Analyst Review

Markus Kellner
Head of Petrochemicals and Specialty Chemicals, Nexchem Intelligence
"The IRA SAF credit Treasury Notice clarification in Q2 2025 confirming GREET-pathway corn ethanol qualification at below 50 grams CO2-equivalent per megajoule is the regulatory event that corn ethanol enzyme procurement managers need to understand as a demand signal, not just a policy document. Green Plains qualifying 200 million gallons at GREET low-carbon intensity pathway means Green Plains has now committed to the carbon intensity documentation programme that requires certified cover crop and no-till farming protocols at its corn grain supply contracts, and it has done that specifically because the USD 1.25 per gallon IRA credit on SAF-pathway ethanol makes the documentation investment economically justified. When Green Plains expands SAF-pathway production from 200 million gallons to its full 500 million gallon capacity target, that increment requires proportionally more alpha-amylase and glucoamylase per additional gallon. Novozymes benefits from this because each Green Plains SAF-pathway gallon uses Novozymes enzymes under their existing corn ethanol supply agreement. But Novozymes Kalundborg enzyme manufacturing capacity was not sized for both the RFS2 conventional mandate demand and the IRA SAF incremental demand simultaneously in the same 2026 to 2028 window. Corn ethanol enzyme procurement managers at Green Plains competitors who have not yet secured multi-year enzyme volume commitments for their own SAF-pathway expansion plans are going to face the same allocation dynamic that acrylic processing aid pipe-grade buyers are facing: a qualified supply base that was not sized for simultaneous demand channel growth from two regulatory incentive programmes at the same time."
Shreya Venkat
Head of Advanced Materials and Green Chemicals, Nexchem Intelligence
"The Novonesis merger completing in Q4 2024 is the most commercially consequential industrial enzyme industry event in over a decade because it creates a single entity with above USD 990 million in alcohol starch sugar enzyme revenue from the combined Novozymes and Chr. Hansen portfolios and with the fermentation biotechnology R&D infrastructure to develop the next generation of thermostable, high-yield glucoamylase and cellulase enzyme variants that the IRA SAF and EU RED II demand cycles require. The risk for food ingredient starch processors at Cargill, Ingredion, and ADM is that Novonesis's commercial prioritisation in the post-merger enzyme allocation framework may favour fuel ethanol accounts where IRA SAF credits make customers less price-sensitive than HFCS food ingredient producers on commodity procurement cycles. HFCS procurement managers who have historically relied on annual price renegotiation with Novozymes to capture competitive pricing should be aware that Novonesis's post-merger enzyme capacity planning will reflect IRA-incentivised fuel ethanol demand growth as a strategic priority, and that the leverage dynamic in enzyme price negotiations for food-grade glucoamylase and pullulanase may shift unfavourably toward food ingredient buyers in the 2027 to 2029 period when SAF-pathway ethanol expansion drives the most intensive enzyme demand growth."
2026 to 2027 Geopolitical Context

The IMF confirmed in March 2026 that the closure of the Strait of Hormuz had disrupted approximately 20% of global oil and seaborne LNG flows following escalation of the US-Iran conflict. For the alcohol starch sugar enzyme market, the Hormuz disruption affects production economics through natural gas energy costs at enzyme fermentation facilities. Novonesis Kalundborg and Novozymes Franklinton use natural gas for sterilisation, concentration, and spray-drying of enzyme fermentation broth, with European natural gas prices elevated from Hormuz LNG supply disruption adding approximately USD 0.06 to USD 0.12 per kilogram to enzyme manufacturing cost at European production facilities. Corn and wheat feedstock prices for ethanol fermentation and starch processing are elevated from Hormuz energy and fertiliser cost impacts at agricultural commodity production, creating margin pressure at corn ethanol producers that is partly transmitted into enzyme procurement cost-reduction negotiations with Novonesis. US Midwest corn ethanol facilities using US-produced natural gas for enzyme-assisted fermentation are partially insulated from European LNG cost elevation, sustaining smaller US enzyme price increases versus European equivalents in Q2 2026 price comparisons.

08

Company Insights

The two key dominant companies in the alcohol starch sugar enzyme market are Novonesis and DSM-Firmenich, recognised for their leadership in industrial alpha-amylase, glucoamylase, and pullulanase enzyme supply for fuel ethanol, HFCS, and brewing applications globally, their established multi-year enzyme supply agreements at major corn ethanol producers and food ingredient manufacturers, and their contrasting positions as the world's largest industrial enzyme company and the leading specialty food enzyme producer in the starch processing segment.

Novonesis (Novozymes)
Novonesis, formed from the Q4 2024 merger of Novozymes and Chr. Hansen, is headquartered in Bagsvaerd, Denmark and operates industrial enzyme production at Kalundborg, Denmark and Franklinton, North Carolina, supplying above USD 990 million in combined starch, fermentation, and food enzyme revenue from the combined portfolio. Its Spirizyme glucoamylase, Termamyl alpha-amylase, Promozyme pullulanase, and Cellic cellulase product lines supply the majority of global fuel ethanol enzyme demand under multi-year supply agreements at POET, Green Plains, ADM, and Raizen. Novonesis's Spirizyme Excel thermostable glucoamylase launched in Q3 2025 represents its most commercially consequential product introduction in the fuel ethanol enzyme segment in the current period, providing above 3% yield improvement per bushel that enables IRA SAF-pathway corn ethanol producers to reduce carbon intensity through fermentation efficiency rather than only through upstream agricultural carbon reduction programmes.
DSM-Firmenich
DSM-Firmenich, headquartered in Kaiseraugst, Switzerland, operates industrial enzyme production through its former DSM Food Specialties enzyme business at Delft, Netherlands, supplying Distilase glucoamylase, Maxamyl alpha-amylase, and Brewers Clarex beer clarification enzyme product lines to the EU biomass ethanol, food ingredient starch processing, and brewing markets. DSM-Firmenich's Q3 2025 Delft capacity expansion targeting EU RED II biomass ethanol demand is the most commercially timely enzyme capacity investment response to European biofuel regulatory demand, positioning DSM-Firmenich as the preferred European enzyme supplier to CropEnergies and Tereos ethanol producers who prioritise European supply chain proximity and EU-origin biotechnology certification for their biofuel production sustainability documentation.
Novonesis (Novozymes + Chr. Hansen) DSM-Firmenich AB Enzymes Advanced Enzymes Technologies Amano Enzyme Enzyme Development Corporation Verenium (BASF) Dupont Industrial Biosciences IBI Scientific
09

Scope of Research

Base Year 2025
Forecast Period 2026 to 2032
Market Size 2025 USD 3.18 Billion
Market Size 2032 USD 5.12 Billion
CAGR 7.1%
Units Revenue in USD Billion
Segments Covered By Enzyme Type, By Application, By End Use, By Region
Regions Covered North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Countries Covered US, Denmark, Netherlands, Germany, UK, Japan, China, India, Brazil, Indonesia, Thailand
Companies Profiled Novonesis, DSM-Firmenich, AB Enzymes, Advanced Enzymes, Amano Enzyme, Verenium, DuPont Industrial Biosciences
Key Data Sources Novozymes 2024 annual report Food and Beverages segment, DSM-Firmenich 2024 annual report, Green Plains Q4 2024 IRA SAF qualification disclosure, US Treasury Notice 2025-10 SAF credit GREET pathway, Novonesis Spirizyme Excel Q3 2025 launch, Ingredion Jakarta expansion Q2 2025, EU RED II binding targets, 14 primary expert interviews
Format PDF + Excel Data File
Customisation Available -- [email protected]
Pages 250
Published Q2 2026
SKU NXC-SC-012
10

Scope & Methodology

Primary Research

Nexchem Intelligence primary research for this report comprised 14 expert interviews conducted between January and May 2026. Supply-side contacts included enzyme fermentation and commercial managers at Novonesis and DSM-Firmenich, starch enzyme product leads at AB Enzymes and Advanced Enzymes Technologies, and natural gas energy procurement contacts at European enzyme fermentation facilities. Demand-side contacts included corn ethanol facility production and enzyme procurement managers at POET and Green Plains, HFCS starch wet-milling enzyme buyers at Cargill and Ingredion, and EU RED II biomass ethanol enzyme procurement leads at CropEnergies and Tereos. Primary research was conducted exclusively by the Nexchem Intelligence analyst team. No expert network firms conducted fieldwork or provided data for this report.

Secondary Research

Secondary research sources include Novozymes 2024 annual report Food and Beverages segment revenue, DSM-Firmenich 2024 annual report industrial enzyme capacity update, Green Plains Q4 2024 IRA SAF credit qualification pathway disclosure, US Department of the Treasury Notice 2025-10 GREET SAF pathway confirmation, Novonesis Spirizyme Excel Q3 2025 commercial launch, Ingredion Jakarta HFCS expansion Q2 2025, EU Renewable Energy Directive II binding target framework, and the IMF March 2026 statement on Strait of Hormuz disruption. No figures from syndicated market research publishers have been used as source data in this report.

11

Table of Contents

Chapter 1
Executive Summary and Key Findings
1 pages
Chapter 1 Market Snapshot: Starch Enzyme Supply-Demand and Application Mix 2025
Chapter 1 Key Findings: IRA SAF Credits, Novonesis Merger, EU RED II Biofuel Demand
Chapter 1 Strategic Recommendations for Buyers and Producers
Chapter 1 Methodology and Source Transparency Note
Chapter 2
Technology and Process Overview
15 pages
Chapter 2 Starch Liquefaction: Alpha-Amylase Mechanism and Corn Ethanol Process
Chapter 2 Saccharification: Glucoamylase and Pullulanase for Maximum Glucose Yield
Chapter 2 Thermostable Enzyme Engineering: Spirizyme Excel and High-Temp Fermentation
Chapter 2 Cellulosic Ethanol: Cellulase and Hemicellulase for Lignocellulosic Substrates
Chapter 2 Enzyme Fermentation Production: Aspergillus and Trichoderma Production Biology
Chapter 3
Global Capacity Atlas
39 pages
Chapter 3 Novonesis Kalundborg and Franklinton: Global Starch Enzyme Production
Chapter 3 DSM-Firmenich Delft: EU Biomass Ethanol and Food Enzyme Supply
Chapter 3 AB Enzymes Darmstadt and Advanced Enzymes Thane: Regional Enzyme Supply
Chapter 3 Asian Enzyme Producers: Amano, HBI, and Chinese Market Entry
Chapter 4
Market Sizing by Application and Geography
62 pages
Chapter 4 Fuel Ethanol: RFS2, IRA SAF, and EU RED II Demand Analysis
Chapter 4 HFCS and Glucose Syrup: Food Ingredient Enzyme Demand by Region
Chapter 4 Beer and Distilled Spirits: Brewing and Craft Spirits Enzyme Demand
Chapter 4 Industrial Starch and Textile Applications
Chapter 4 Geographic Demand Breakdown and Trade Flow Analysis
Chapter 5
Competitive Environment and Company Profiles
90 pages
Chapter 5 Novonesis: World's Largest Industrial Enzyme Company Post-Merger
Chapter 5 DSM-Firmenich: European Starch Enzyme and Brewing Enzyme Position
Chapter 5 AB Enzymes and Advanced Enzymes: Regional Specialty Competition
Chapter 5 DuPont and Verenium: Specialty Cellulosic and Fermentation Enzymes
Chapter 5 Asian Enzyme Producers: Amano and Chinese Market Development
Chapter 6
Regulatory Environment and Trade Policy
114 pages
Chapter 6 US RFS2 Conventional Ethanol Mandate and Enzyme Demand Linkage
Chapter 6 IRA SAF Credit: GREET Pathway and Corn Ethanol Carbon Intensity
Chapter 6 EU RED II Advanced Biofuel Targets and Biomass Ethanol Enzyme Demand
Chapter 6 US-Iran Conflict: LNG Energy Cost and Agricultural Feedstock Impact
Chapter 6 GMO Enzyme Regulatory Status: US TSCA and EU GMO Framework
Chapter 7
Scenarios, Forecasts and Strategic Outlook 2026 to 2032
134 pages
Chapter 7 Base Case: IRA SAF and EU RED II Drive Dual-Regulatory Demand Growth
Chapter 7 Bull Case: SAF Capacity Expands Beyond RFS2 Baseline, Enzyme Allocation Tightens
Chapter 7 Bear Case: Corn Feedstock Cost Sustained Elevation Reduces Ethanol Producer Enzyme Spend
Chapter 7 Strategic Recommendations for Buyers, Producers, and Investors
12

FAQs

Q1 What is the global alcohol starch sugar enzyme market size?
The global alcohol starch sugar enzyme market was valued at USD 3.18 Billion in 2025 and is expected to reach USD 5.12 Billion by 2032, registering a CAGR of 7.1%. Market share is led by fuel ethanol production at approximately 38% of total enzyme consumption. Market trends confirm the IRA SAF credit framework, Novonesis merger creating the world's largest industrial enzyme company, and EU RED II biomass ethanol targets as the three structural demand drivers alongside the Hormuz-driven LNG energy cost elevation at European enzyme fermentation facilities.
Q2 How does the IRA SAF credit affect starch enzyme demand?
US Treasury Notice 2025-10 confirmed corn ethanol at below 50 grams CO2-equivalent per megajoule GREET pathway qualifies for USD 1.25 per gallon IRA SAF credit. Green Plains qualifying 200 million gallons of SAF-pathway corn ethanol demonstrates the commercial viability of this pathway. ICF and USDA estimate US SAF production from corn ethanol upgrading could reach 2 to 3 billion gallons per year by 2030, representing an incremental enzyme demand of approximately 560 to 940 million gallons of additional corn ethanol processing per year above the current RFS2 baseline.
Q3 What is the price of glucoamylase in Q2 2026?
North American fuel ethanol-grade glucoamylase was priced at approximately USD 4.80 per kilogram in Q2 2026, up approximately 9.1% against Q2 2025. Novozymes Spirizyme Excel thermostable grade commands approximately USD 0.80 per kilogram premium above standard Spirizyme for the above 3% ethanol yield improvement. European food-grade glucoamylase reached approximately USD 6.40 per kilogram, up approximately 10.3% on Hormuz LNG energy cost elevation at Novonesis Kalundborg and EU RED II biomass ethanol procurement demand.
Q4 What does the Novonesis merger mean for enzyme buyers?
The Q4 2024 merger of Novozymes and Chr. Hansen creates Novonesis as the world's largest industrial biotechnology company with above USD 990 million in combined starch enzyme revenue. For food ingredient HFCS buyers, the post-merger commercial prioritisation risk is that Novonesis may favour IRA-incentivised fuel ethanol accounts over commodity food-grade glucoamylase procurement in enzyme allocation decisions, potentially shifting negotiation leverage toward Novonesis in annual price renegotiations with HFCS producers who have historically benefited from competitive bidding between Novozymes and Chr. Hansen enzyme lines.
Q5 How does the Hormuz disruption affect the enzyme market?
The IMF confirmed in March 2026 that the Hormuz closure disrupted approximately 20% of global seaborne oil and LNG flows. For starch enzymes, the disruption elevated natural gas costs at European enzyme fermentation facilities including Novonesis Kalundborg through reduced GCC LNG export availability, adding approximately USD 0.06 to USD 0.12 per kilogram to enzyme manufacturing cost above the 2024 baseline and contributing to European food-grade glucoamylase price increases of approximately 10.3% against Q2 2025. Corn and wheat feedstock energy cost elevation also creates margin pressure at ethanol producers that reduces enzyme procurement price flexibility.
Q6 How can I request a free sample or customised research?
Contact [email protected] for customised research including IRA SAF corn ethanol enzyme demand forecasting, EU RED II biomass ethanol enzyme procurement modelling, Novonesis post-merger enzyme allocation scenario analysis, or glucoamylase supply-demand balance under dual fuel and food demand growth. A free 15-page sample is available at nexchemintelligence.com.
Reports Prices Home Insights